Mayo Clinic Florida in Jacksonville has entered into a collaborative agreement with a South Korean biopharmaceuticals company with the goal of developing new treatments for Amyotrophic Lateral Sclerosis, or Lou Gehrig’s disease. The agreement with SK Biopharmaceuticals is based on research spearheaded by Dr. Leonard Petrucelli, a neuroscientist and chairman of the neuroscience research department at Mayo Clinic Florida.

Jacksonville Business Journal, Ashley Kritzer, 9/20/11

Additional coverage: Science Business, Sun Herald, Enhanced Online News, Pharmaceutical Business Review

Tags: Mayo Clinic Jacksonville